Pharmacyte BiotechPMCB
13F holders, Q4 2024 (December 31)21holders −5
0new positions
5sold out
1famous investor
$1.56avg. 13F price*
At the end of Q4 2024, 21 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings, down 5 from Q3 2024. 0 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($298K), Geode Capital Management, LLC ($255K) and Equitec Proprietary Markets, LLC ($130K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 5 | $406K |
All 13F filers, Q3 2024 → Q4 2024: 78 shares bought and 225,461 shares sold, net −225,383 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Vanguard Group Inc. | 0.00% | No change | 192,387 | $298K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.1% | 164,736 | $255K |
| Equitec Proprietary Markets, LLC | 0.89% | No change | 82,727 | $130K |
| Renaissance Technologies | 0.00% | Reduce -0.8% | 49,300 | $77K |
| Susquehanna International Group, LLP | 0.00% | Reduce -2.1% | 34,481 | $53K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -2.8% | 26,841 | $42K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -0.8% | 25,700 | $40K |
| Northern Trust Corp. | 0.00% | No change | 19,208 | $30K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -14.5% | 2,445 | $4K |
| UBS Group AG | 0.00% | Reduce -77.6% | 1,874 | $3K |
| Osaic Holdings, Inc. | 0.00% | Add +5.7% | 537 | $841 |
| Bank of America Corp. | 0.00% | Reduce -33.3% | 78 | $123 |
| Park Square Financial Group, LLC | 0.00% | — | 37 | $58 |
| JPMorgan Chase & Co. | 0.00% | No change | 18 | $28 |
| Sachetta, LLC | 0.00% | No change | 14 | $22 |
| Bfsg, LLC | 0.00% | No change | 5 | $8 |
| Morgan Stanley | 0.00% | No change | 2 | $4 |
| NewEdge Advisors, LLC | 0.00% | No change | 2 | $3 |
| Royal Bank of Canada | 0.00% | Reduce -2.0% | 98 | $0 |
| Cwm, LLC | 0.00% | No change | 1 | $0 |
| Covestor Ltd | 0.00% | Add +21.7% | 275 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.